Sloppy Validation, Complaint Handling Found at Duke Empirical

The GMP Letter
Process validation issues and failure to document complaints and corrective and preventive actions landed devicemaker Duke Empirical an FDA Form 483 following a Dec. 3-21, 2018, inspection of its Santa Cruz, California plant.

To View This Article:


Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $157.00